<DOC>
	<DOCNO>NCT02475486</DOCNO>
	<brief_summary>Despite large therapeutic arsenal available since one decade allow strong reduction inflammation process , rheumatoid arthritis ( RA ) patient claim pain , fatigue , sleep problem quality life outcome . Fatigue reduction TNF blocker therapy low strong reduction RA disease activity . Furthermore , RA patient high prevalence non-inflammatory pain general population . Fatigue real major problem due 50 % patient consider severe . This dissociation disease activity fatigue level suggest fatigue multifactorial . No consistent explanation fatigue currently available .</brief_summary>
	<brief_title>Role ANS Dysregulation Persistence Fatigue Rheumatoid Arthritis Patients Treated With Anti-TNF</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<criteria>RA diagnosis accord ACR/EULAR 2010 RA low disease activity accord DAS28 &lt; 3.2 visual analog scale fatigue low ( ≤ 3 ) visual analog scale fatigue high ( ≥ 7 ) Written consent obtain Other diagnosis RA Depression know Hypertension treat , Diseases interfere ANS analysis : cardiac arrhythmia , betablocker therapy , Pregnant breastfeed woman , Inability go two consecutive day North hospital delivery return Vista02 device</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>sympathetic nervous system</keyword>
	<keyword>SNA</keyword>
	<keyword>fatigue</keyword>
</DOC>